Donepezil
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Synonyms / Brand Names: Donepezil hydrochloride, Aricept, Aricept ODT, Eranz
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Dosing and Administration
Mild to Moderate Alzheimer's Disease: The dosages of Aricept® shown to be effective in controlled clinical trials are 5 mg and 10 mg administered once per day.
Severe Alzheimer's Disease: Aricept® has been shown to be effective in controlled clinical trials at a dose of 10 mg administered once daily.
Aricept® should be taken in the evening, just prior to retiring. Aricept® can be taken with or without food.
Allow Aricept® ODT tablet to dissolve on the tongue and follow with water.
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Donepezil
Return to top
Publication Resources
Most Recent Articles on Donepezil
Review Articles on Donepezil
Articles on Donepezil in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Donepezil
Return to top
Trial Resources
Ongoing Trials with Donepezil at Clinical Trials.gov
Trial Results with Donepezil
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Donepezil
Cochrane Collaboration on Donepezil
Cost Effectiveness of Donepezil
Return to top
Media Resources
Powerpoint Slides on Donepezil
Images of Donepezil
Podcasts & MP3s on Donepezil
Videos on Donepezil
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Donepezil
Discussion Groups on Donepezil
Patient Handouts on Donepezil
Blogs on Donepezil
Donepezil in the News
Donepezil in the Marketplace
Return to top
International Resources
Donepezil en Español
Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
